Is progression in comorbidity before hemodialysis initiation a valuable predictor of survival in incident patients?
The CCI-3 and CCIp before HD initiation are valuable predictors of survival in incident patients.
Carrier-bound Der p 2 peptides should allow avoiding IgE-mediated side-effects, and because of their low potential to activate allergen-specific T cells, they may reduce late-phase side-effects during SIT. Further, these peptides may be also useful for prophylactic vaccination.